Inhibitory effect of specific siRNA on CVB3-VP1 expression in HeLa cells
CHEN Jie-bin,XU Cong-feng,CHEN Rui-zhen,YU Yong,LI Li,DU Jiu-zhong,GUO Qi,YANG Ying-zhen,DENG Hui,LI Shuang-jie,陈杰斌,许从峰,陈瑞珍,虞勇,李丽,杜九中,郭棋,杨英珍,邓晖,李双杰
DOI: https://doi.org/10.3760/j:issn:0254-5101.2006.07.002
2006-01-01
Abstract:Objective To investigate dose-dependence regulatory inhibition and time-effect relationship between CVB3-VP1 siRNA and the expression of CVB3-VP1 in HeLa cells. Methods Four differents dose siRNA were transfected into HeLa cells by liposome (IipofectAMINETM2000). 24, 48, 72, 96 h later, the CVB3-VP1 protein expression were detected by immunofluorescence, and CVB3 mRNA level was tested by semi-quantitative RT-PCR. Results Observations have showed that 60 pmol/L CVB3-VP1 siRNA was the optimal dose, and the inhibitory effect on CVB3-VP1 expression was the optimum after transfection 48 h. Conclusion Specific siRNA have the dose-dependence and time-effect relationship to the expression level of CVB3-VP1. These results suggested a feasibility of using RNAi to elucidate pathogenesis of CVB3 myocarditis and that RNAi might represent a new approach for the treatment of CVB3 myocarditis.